Abstract

Abstract Background Advancement in molecular biology research has allowed the measurement of multiomics data points from a single tumor biopsy sample in a reasonable time frame for making significant clinical decisions. There have been tremendous advances from the bioinformatics and systems biology perspective to analyse integrated multi‐scale analysis of the data will prove invaluable for a combined systems‐level understanding of the important biological network processes contributing to the initiation, progression and management of cancer. Cancer networks have greater challenge due to the aberrant functions of hundreds of genes that are translated to altered protein function within each cancer cell, to understand this complexity. Network-based methods have been used to analyse the complexity molecular interactions in the cell and can contribute to prediction of candidate genes responsible for cancer. Methods HI-II- 14 is the largest experimentally determined binary protein – protein interaction map is used for the study. These interactions were mapped to NCBI Entrez gene ID and excluded self-loop and redundant interactions. The known human breast cancer genes were obtained from the Sanger Cancer Gene Census which is a comprehensive catalogue of genes implicated in breast cancer and from Uniprot database. In total, we obtained 913 genes from both for analyses. The genes degree of connections and the centrality in the protein -protein networks were considered. The genome-wide mutation datasets of breast cancer were downloaded from TCGA as maf files. For each gene, we obtained the mutation frequency for each gene is calculated which is defined as the number of mutated samples divided by the total number of samples. The frequency of the top 100 ranked genes and the bottom 100 ranked genes were compared by Wilcox rank sum test. Results In this study, HI-II-14 human protein-protein interactome network is applied to prediction of novel breast cancer genes. Conclusions Our study suggests integrating interactome networks with multiomics datasets could provide novel insights into breast cancer-associated genes and underlying molecular mechanisms. Legal entity responsible for the study M. Peer Mohammed. Funding Has not received any funding. Disclosure The author has declared no conflicts of interest.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.